Interleukin-7 Receptor alpha Subunit
"Interleukin-7 Receptor alpha Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A low affinity interleukin-7 receptor subunit that combines with the INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT to form a high affinity receptor for INTERLEUKIN-7.
| Descriptor ID |
D053699
|
| MeSH Number(s) |
D12.776.543.750.705.852.420.420.450
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Interleukin-7 Receptor alpha Subunit".
Below are MeSH descriptors whose meaning is more specific than "Interleukin-7 Receptor alpha Subunit".
This graph shows the total number of publications written about "Interleukin-7 Receptor alpha Subunit" by people in this website by year, and whether "Interleukin-7 Receptor alpha Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 0 | 2 | 2 |
| 2015 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Interleukin-7 Receptor alpha Subunit" by people in Profiles.
-
Group 2 innate lymphoid cells are elevated and activated in chronic rhinosinusitis with nasal polyps. Immun Inflamm Dis. 2017 09; 5(3):233-243.
-
Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders. Oncotarget. 2016 Nov 29; 7(48):79474-79484.
-
The transcription factor lymphoid enhancer factor 1 controls invariant natural killer T cell expansion and Th2-type effector differentiation. J Exp Med. 2015 May 04; 212(5):793-807.
-
Basal NF-?B controls IL-7 responsiveness of quiescent naïve T cells. Proc Natl Acad Sci U S A. 2014 May 20; 111(20):7397-402.
-
Therapy of type 1 diabetes with CD4(+)CD25(high)CD127-regulatory T cells prolongs survival of pancreatic islets - results of one year follow-up. Clin Immunol. 2014 Jul; 153(1):23-30.
-
Administration of CD4+CD25highCD127- regulatory T cells preserves ß-cell function in type 1 diabetes in children. Diabetes Care. 2012 Sep; 35(9):1817-20.
-
The time is crucial for ex vivo expansion of T regulatory cells for therapy. Cell Transplant. 2011; 20(11-12):1747-58.